Medical Care
Global Cancer Early Detection and Diagnosis Market Research Report 2025
- May 12, 25
- ID: 234580
- Pages: 88
- Figures: 87
- Views: 4
The global market for Cancer Early Detection and Diagnosis was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cancer early detection and diagnosis are crucial in improving treatment outcomes and patient survival rates. Early detection involves identifying cancer at its earliest stages, even before symptoms become apparent.
North American market for Cancer Early Detection and Diagnosis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Early Detection and Diagnosis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Early Detection and Diagnosis in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Early Detection and Diagnosis include Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic, Epigenomics, Abbott, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Early Detection and Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Early Detection and Diagnosis.
The Cancer Early Detection and Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Early Detection and Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Early Detection and Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Exact Sciences
Grail
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
Oncognostic
Epigenomics
Abbott
Qiagen
iStat Biomedical
Segment by Type
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
Segment by Application
Hospital
Medical Center
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Early Detection and Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cancer early detection and diagnosis are crucial in improving treatment outcomes and patient survival rates. Early detection involves identifying cancer at its earliest stages, even before symptoms become apparent.
North American market for Cancer Early Detection and Diagnosis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Early Detection and Diagnosis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Early Detection and Diagnosis in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Early Detection and Diagnosis include Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic, Epigenomics, Abbott, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Early Detection and Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Early Detection and Diagnosis.
The Cancer Early Detection and Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Early Detection and Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Early Detection and Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Exact Sciences
Grail
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
Oncognostic
Epigenomics
Abbott
Qiagen
iStat Biomedical
Segment by Type
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
Segment by Application
Hospital
Medical Center
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Early Detection and Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Early Detection and Diagnosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Colorectal Cancer
1.2.3 Liver Cancer
1.2.4 Lung Cancer
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cancer Early Detection and Diagnosis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Medical Center
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Early Detection and Diagnosis Market Perspective (2020-2031)
2.2 Global Cancer Early Detection and Diagnosis Growth Trends by Region
2.2.1 Global Cancer Early Detection and Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Early Detection and Diagnosis Historic Market Size by Region (2020-2025)
2.2.3 Cancer Early Detection and Diagnosis Forecasted Market Size by Region (2026-2031)
2.3 Cancer Early Detection and Diagnosis Market Dynamics
2.3.1 Cancer Early Detection and Diagnosis Industry Trends
2.3.2 Cancer Early Detection and Diagnosis Market Drivers
2.3.3 Cancer Early Detection and Diagnosis Market Challenges
2.3.4 Cancer Early Detection and Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Early Detection and Diagnosis Players by Revenue
3.1.1 Global Top Cancer Early Detection and Diagnosis Players by Revenue (2020-2025)
3.1.2 Global Cancer Early Detection and Diagnosis Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Early Detection and Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Early Detection and Diagnosis Revenue
3.4 Global Cancer Early Detection and Diagnosis Market Concentration Ratio
3.4.1 Global Cancer Early Detection and Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Early Detection and Diagnosis Revenue in 2024
3.5 Global Key Players of Cancer Early Detection and Diagnosis Head office and Area Served
3.6 Global Key Players of Cancer Early Detection and Diagnosis, Product and Application
3.7 Global Key Players of Cancer Early Detection and Diagnosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Early Detection and Diagnosis Breakdown Data by Type
4.1 Global Cancer Early Detection and Diagnosis Historic Market Size by Type (2020-2025)
4.2 Global Cancer Early Detection and Diagnosis Forecasted Market Size by Type (2026-2031)
5 Cancer Early Detection and Diagnosis Breakdown Data by Application
5.1 Global Cancer Early Detection and Diagnosis Historic Market Size by Application (2020-2025)
5.2 Global Cancer Early Detection and Diagnosis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Early Detection and Diagnosis Market Size (2020-2031)
6.2 North America Cancer Early Detection and Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Early Detection and Diagnosis Market Size by Country (2020-2025)
6.4 North America Cancer Early Detection and Diagnosis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Early Detection and Diagnosis Market Size (2020-2031)
7.2 Europe Cancer Early Detection and Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Early Detection and Diagnosis Market Size by Country (2020-2025)
7.4 Europe Cancer Early Detection and Diagnosis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Early Detection and Diagnosis Market Size (2020-2031)
8.2 Asia-Pacific Cancer Early Detection and Diagnosis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Early Detection and Diagnosis Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Early Detection and Diagnosis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Early Detection and Diagnosis Market Size (2020-2031)
9.2 Latin America Cancer Early Detection and Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Early Detection and Diagnosis Market Size by Country (2020-2025)
9.4 Latin America Cancer Early Detection and Diagnosis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Early Detection and Diagnosis Market Size (2020-2031)
10.2 Middle East & Africa Cancer Early Detection and Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Early Detection and Diagnosis Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Early Detection and Diagnosis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Exact Sciences
11.1.1 Exact Sciences Company Details
11.1.2 Exact Sciences Business Overview
11.1.3 Exact Sciences Cancer Early Detection and Diagnosis Introduction
11.1.4 Exact Sciences Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.1.5 Exact Sciences Recent Development
11.2 Grail
11.2.1 Grail Company Details
11.2.2 Grail Business Overview
11.2.3 Grail Cancer Early Detection and Diagnosis Introduction
11.2.4 Grail Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.2.5 Grail Recent Development
11.3 Genetron Health
11.3.1 Genetron Health Company Details
11.3.2 Genetron Health Business Overview
11.3.3 Genetron Health Cancer Early Detection and Diagnosis Introduction
11.3.4 Genetron Health Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.3.5 Genetron Health Recent Development
11.4 New Horizon Health
11.4.1 New Horizon Health Company Details
11.4.2 New Horizon Health Business Overview
11.4.3 New Horizon Health Cancer Early Detection and Diagnosis Introduction
11.4.4 New Horizon Health Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.4.5 New Horizon Health Recent Development
11.5 Burning Rock
11.5.1 Burning Rock Company Details
11.5.2 Burning Rock Business Overview
11.5.3 Burning Rock Cancer Early Detection and Diagnosis Introduction
11.5.4 Burning Rock Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.5.5 Burning Rock Recent Development
11.6 Berry Oncology
11.6.1 Berry Oncology Company Details
11.6.2 Berry Oncology Business Overview
11.6.3 Berry Oncology Cancer Early Detection and Diagnosis Introduction
11.6.4 Berry Oncology Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.6.5 Berry Oncology Recent Development
11.7 Shanghai Kunyuan Biotechnology
11.7.1 Shanghai Kunyuan Biotechnology Company Details
11.7.2 Shanghai Kunyuan Biotechnology Business Overview
11.7.3 Shanghai Kunyuan Biotechnology Cancer Early Detection and Diagnosis Introduction
11.7.4 Shanghai Kunyuan Biotechnology Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.7.5 Shanghai Kunyuan Biotechnology Recent Development
11.8 Oncognostic
11.8.1 Oncognostic Company Details
11.8.2 Oncognostic Business Overview
11.8.3 Oncognostic Cancer Early Detection and Diagnosis Introduction
11.8.4 Oncognostic Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.8.5 Oncognostic Recent Development
11.9 Epigenomics
11.9.1 Epigenomics Company Details
11.9.2 Epigenomics Business Overview
11.9.3 Epigenomics Cancer Early Detection and Diagnosis Introduction
11.9.4 Epigenomics Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.9.5 Epigenomics Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Cancer Early Detection and Diagnosis Introduction
11.10.4 Abbott Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.10.5 Abbott Recent Development
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Cancer Early Detection and Diagnosis Introduction
11.11.4 Qiagen Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.11.5 Qiagen Recent Development
11.12 iStat Biomedical
11.12.1 iStat Biomedical Company Details
11.12.2 iStat Biomedical Business Overview
11.12.3 iStat Biomedical Cancer Early Detection and Diagnosis Introduction
11.12.4 iStat Biomedical Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.12.5 iStat Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Early Detection and Diagnosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Colorectal Cancer
1.2.3 Liver Cancer
1.2.4 Lung Cancer
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cancer Early Detection and Diagnosis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Medical Center
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Early Detection and Diagnosis Market Perspective (2020-2031)
2.2 Global Cancer Early Detection and Diagnosis Growth Trends by Region
2.2.1 Global Cancer Early Detection and Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Early Detection and Diagnosis Historic Market Size by Region (2020-2025)
2.2.3 Cancer Early Detection and Diagnosis Forecasted Market Size by Region (2026-2031)
2.3 Cancer Early Detection and Diagnosis Market Dynamics
2.3.1 Cancer Early Detection and Diagnosis Industry Trends
2.3.2 Cancer Early Detection and Diagnosis Market Drivers
2.3.3 Cancer Early Detection and Diagnosis Market Challenges
2.3.4 Cancer Early Detection and Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Early Detection and Diagnosis Players by Revenue
3.1.1 Global Top Cancer Early Detection and Diagnosis Players by Revenue (2020-2025)
3.1.2 Global Cancer Early Detection and Diagnosis Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Early Detection and Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Early Detection and Diagnosis Revenue
3.4 Global Cancer Early Detection and Diagnosis Market Concentration Ratio
3.4.1 Global Cancer Early Detection and Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Early Detection and Diagnosis Revenue in 2024
3.5 Global Key Players of Cancer Early Detection and Diagnosis Head office and Area Served
3.6 Global Key Players of Cancer Early Detection and Diagnosis, Product and Application
3.7 Global Key Players of Cancer Early Detection and Diagnosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Early Detection and Diagnosis Breakdown Data by Type
4.1 Global Cancer Early Detection and Diagnosis Historic Market Size by Type (2020-2025)
4.2 Global Cancer Early Detection and Diagnosis Forecasted Market Size by Type (2026-2031)
5 Cancer Early Detection and Diagnosis Breakdown Data by Application
5.1 Global Cancer Early Detection and Diagnosis Historic Market Size by Application (2020-2025)
5.2 Global Cancer Early Detection and Diagnosis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Early Detection and Diagnosis Market Size (2020-2031)
6.2 North America Cancer Early Detection and Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Early Detection and Diagnosis Market Size by Country (2020-2025)
6.4 North America Cancer Early Detection and Diagnosis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Early Detection and Diagnosis Market Size (2020-2031)
7.2 Europe Cancer Early Detection and Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Early Detection and Diagnosis Market Size by Country (2020-2025)
7.4 Europe Cancer Early Detection and Diagnosis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Early Detection and Diagnosis Market Size (2020-2031)
8.2 Asia-Pacific Cancer Early Detection and Diagnosis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Early Detection and Diagnosis Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Early Detection and Diagnosis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Early Detection and Diagnosis Market Size (2020-2031)
9.2 Latin America Cancer Early Detection and Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Early Detection and Diagnosis Market Size by Country (2020-2025)
9.4 Latin America Cancer Early Detection and Diagnosis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Early Detection and Diagnosis Market Size (2020-2031)
10.2 Middle East & Africa Cancer Early Detection and Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Early Detection and Diagnosis Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Early Detection and Diagnosis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Exact Sciences
11.1.1 Exact Sciences Company Details
11.1.2 Exact Sciences Business Overview
11.1.3 Exact Sciences Cancer Early Detection and Diagnosis Introduction
11.1.4 Exact Sciences Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.1.5 Exact Sciences Recent Development
11.2 Grail
11.2.1 Grail Company Details
11.2.2 Grail Business Overview
11.2.3 Grail Cancer Early Detection and Diagnosis Introduction
11.2.4 Grail Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.2.5 Grail Recent Development
11.3 Genetron Health
11.3.1 Genetron Health Company Details
11.3.2 Genetron Health Business Overview
11.3.3 Genetron Health Cancer Early Detection and Diagnosis Introduction
11.3.4 Genetron Health Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.3.5 Genetron Health Recent Development
11.4 New Horizon Health
11.4.1 New Horizon Health Company Details
11.4.2 New Horizon Health Business Overview
11.4.3 New Horizon Health Cancer Early Detection and Diagnosis Introduction
11.4.4 New Horizon Health Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.4.5 New Horizon Health Recent Development
11.5 Burning Rock
11.5.1 Burning Rock Company Details
11.5.2 Burning Rock Business Overview
11.5.3 Burning Rock Cancer Early Detection and Diagnosis Introduction
11.5.4 Burning Rock Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.5.5 Burning Rock Recent Development
11.6 Berry Oncology
11.6.1 Berry Oncology Company Details
11.6.2 Berry Oncology Business Overview
11.6.3 Berry Oncology Cancer Early Detection and Diagnosis Introduction
11.6.4 Berry Oncology Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.6.5 Berry Oncology Recent Development
11.7 Shanghai Kunyuan Biotechnology
11.7.1 Shanghai Kunyuan Biotechnology Company Details
11.7.2 Shanghai Kunyuan Biotechnology Business Overview
11.7.3 Shanghai Kunyuan Biotechnology Cancer Early Detection and Diagnosis Introduction
11.7.4 Shanghai Kunyuan Biotechnology Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.7.5 Shanghai Kunyuan Biotechnology Recent Development
11.8 Oncognostic
11.8.1 Oncognostic Company Details
11.8.2 Oncognostic Business Overview
11.8.3 Oncognostic Cancer Early Detection and Diagnosis Introduction
11.8.4 Oncognostic Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.8.5 Oncognostic Recent Development
11.9 Epigenomics
11.9.1 Epigenomics Company Details
11.9.2 Epigenomics Business Overview
11.9.3 Epigenomics Cancer Early Detection and Diagnosis Introduction
11.9.4 Epigenomics Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.9.5 Epigenomics Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Cancer Early Detection and Diagnosis Introduction
11.10.4 Abbott Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.10.5 Abbott Recent Development
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Cancer Early Detection and Diagnosis Introduction
11.11.4 Qiagen Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.11.5 Qiagen Recent Development
11.12 iStat Biomedical
11.12.1 iStat Biomedical Company Details
11.12.2 iStat Biomedical Business Overview
11.12.3 iStat Biomedical Cancer Early Detection and Diagnosis Introduction
11.12.4 iStat Biomedical Revenue in Cancer Early Detection and Diagnosis Business (2020-2025)
11.12.5 iStat Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cancer Early Detection and Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Colorectal Cancer
Table 3. Key Players of Liver Cancer
Table 4. Key Players of Lung Cancer
Table 5. Key Players of Other
Table 6. Global Cancer Early Detection and Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Cancer Early Detection and Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cancer Early Detection and Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Cancer Early Detection and Diagnosis Market Share by Region (2020-2025)
Table 10. Global Cancer Early Detection and Diagnosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Cancer Early Detection and Diagnosis Market Share by Region (2026-2031)
Table 12. Cancer Early Detection and Diagnosis Market Trends
Table 13. Cancer Early Detection and Diagnosis Market Drivers
Table 14. Cancer Early Detection and Diagnosis Market Challenges
Table 15. Cancer Early Detection and Diagnosis Market Restraints
Table 16. Global Cancer Early Detection and Diagnosis Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Cancer Early Detection and Diagnosis Market Share by Players (2020-2025)
Table 18. Global Top Cancer Early Detection and Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Detection and Diagnosis as of 2024)
Table 19. Ranking of Global Top Cancer Early Detection and Diagnosis Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Cancer Early Detection and Diagnosis Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Cancer Early Detection and Diagnosis, Headquarters and Area Served
Table 22. Global Key Players of Cancer Early Detection and Diagnosis, Product and Application
Table 23. Global Key Players of Cancer Early Detection and Diagnosis, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Early Detection and Diagnosis Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Cancer Early Detection and Diagnosis Revenue Market Share by Type (2020-2025)
Table 27. Global Cancer Early Detection and Diagnosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Cancer Early Detection and Diagnosis Revenue Market Share by Type (2026-2031)
Table 29. Global Cancer Early Detection and Diagnosis Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Cancer Early Detection and Diagnosis Revenue Market Share by Application (2020-2025)
Table 31. Global Cancer Early Detection and Diagnosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Cancer Early Detection and Diagnosis Revenue Market Share by Application (2026-2031)
Table 33. North America Cancer Early Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Cancer Early Detection and Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Cancer Early Detection and Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Cancer Early Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Cancer Early Detection and Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Cancer Early Detection and Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Cancer Early Detection and Diagnosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Cancer Early Detection and Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Cancer Early Detection and Diagnosis Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Cancer Early Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Cancer Early Detection and Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cancer Early Detection and Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Cancer Early Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Cancer Early Detection and Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Cancer Early Detection and Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 48. Exact Sciences Company Details
Table 49. Exact Sciences Business Overview
Table 50. Exact Sciences Cancer Early Detection and Diagnosis Product
Table 51. Exact Sciences Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 52. Exact Sciences Recent Development
Table 53. Grail Company Details
Table 54. Grail Business Overview
Table 55. Grail Cancer Early Detection and Diagnosis Product
Table 56. Grail Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 57. Grail Recent Development
Table 58. Genetron Health Company Details
Table 59. Genetron Health Business Overview
Table 60. Genetron Health Cancer Early Detection and Diagnosis Product
Table 61. Genetron Health Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 62. Genetron Health Recent Development
Table 63. New Horizon Health Company Details
Table 64. New Horizon Health Business Overview
Table 65. New Horizon Health Cancer Early Detection and Diagnosis Product
Table 66. New Horizon Health Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 67. New Horizon Health Recent Development
Table 68. Burning Rock Company Details
Table 69. Burning Rock Business Overview
Table 70. Burning Rock Cancer Early Detection and Diagnosis Product
Table 71. Burning Rock Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 72. Burning Rock Recent Development
Table 73. Berry Oncology Company Details
Table 74. Berry Oncology Business Overview
Table 75. Berry Oncology Cancer Early Detection and Diagnosis Product
Table 76. Berry Oncology Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 77. Berry Oncology Recent Development
Table 78. Shanghai Kunyuan Biotechnology Company Details
Table 79. Shanghai Kunyuan Biotechnology Business Overview
Table 80. Shanghai Kunyuan Biotechnology Cancer Early Detection and Diagnosis Product
Table 81. Shanghai Kunyuan Biotechnology Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 82. Shanghai Kunyuan Biotechnology Recent Development
Table 83. Oncognostic Company Details
Table 84. Oncognostic Business Overview
Table 85. Oncognostic Cancer Early Detection and Diagnosis Product
Table 86. Oncognostic Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 87. Oncognostic Recent Development
Table 88. Epigenomics Company Details
Table 89. Epigenomics Business Overview
Table 90. Epigenomics Cancer Early Detection and Diagnosis Product
Table 91. Epigenomics Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 92. Epigenomics Recent Development
Table 93. Abbott Company Details
Table 94. Abbott Business Overview
Table 95. Abbott Cancer Early Detection and Diagnosis Product
Table 96. Abbott Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 97. Abbott Recent Development
Table 98. Qiagen Company Details
Table 99. Qiagen Business Overview
Table 100. Qiagen Cancer Early Detection and Diagnosis Product
Table 101. Qiagen Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 102. Qiagen Recent Development
Table 103. iStat Biomedical Company Details
Table 104. iStat Biomedical Business Overview
Table 105. iStat Biomedical Cancer Early Detection and Diagnosis Product
Table 106. iStat Biomedical Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 107. iStat Biomedical Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Cancer Early Detection and Diagnosis Picture
Figure 2. Global Cancer Early Detection and Diagnosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Early Detection and Diagnosis Market Share by Type: 2024 VS 2031
Figure 4. Colorectal Cancer Features
Figure 5. Liver Cancer Features
Figure 6. Lung Cancer Features
Figure 7. Other Features
Figure 8. Global Cancer Early Detection and Diagnosis Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Cancer Early Detection and Diagnosis Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Medical Center Case Studies
Figure 12. Other Case Studies
Figure 13. Cancer Early Detection and Diagnosis Report Years Considered
Figure 14. Global Cancer Early Detection and Diagnosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Cancer Early Detection and Diagnosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Cancer Early Detection and Diagnosis Market Share by Region: 2024 VS 2031
Figure 17. Global Cancer Early Detection and Diagnosis Market Share by Players in 2024
Figure 18. Global Top Cancer Early Detection and Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Detection and Diagnosis as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Cancer Early Detection and Diagnosis Revenue in 2024
Figure 20. North America Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Cancer Early Detection and Diagnosis Market Share by Country (2020-2031)
Figure 22. United States Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cancer Early Detection and Diagnosis Market Share by Country (2020-2031)
Figure 26. Germany Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cancer Early Detection and Diagnosis Market Share by Region (2020-2031)
Figure 34. China Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cancer Early Detection and Diagnosis Market Share by Country (2020-2031)
Figure 42. Mexico Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cancer Early Detection and Diagnosis Market Share by Country (2020-2031)
Figure 46. Turkey Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Exact Sciences Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 50. Grail Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 51. Genetron Health Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 52. New Horizon Health Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 53. Burning Rock Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 54. Berry Oncology Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 55. Shanghai Kunyuan Biotechnology Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 56. Oncognostic Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 57. Epigenomics Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 58. Abbott Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 59. Qiagen Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 60. iStat Biomedical Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Cancer Early Detection and Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Colorectal Cancer
Table 3. Key Players of Liver Cancer
Table 4. Key Players of Lung Cancer
Table 5. Key Players of Other
Table 6. Global Cancer Early Detection and Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Cancer Early Detection and Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cancer Early Detection and Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Cancer Early Detection and Diagnosis Market Share by Region (2020-2025)
Table 10. Global Cancer Early Detection and Diagnosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Cancer Early Detection and Diagnosis Market Share by Region (2026-2031)
Table 12. Cancer Early Detection and Diagnosis Market Trends
Table 13. Cancer Early Detection and Diagnosis Market Drivers
Table 14. Cancer Early Detection and Diagnosis Market Challenges
Table 15. Cancer Early Detection and Diagnosis Market Restraints
Table 16. Global Cancer Early Detection and Diagnosis Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Cancer Early Detection and Diagnosis Market Share by Players (2020-2025)
Table 18. Global Top Cancer Early Detection and Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Detection and Diagnosis as of 2024)
Table 19. Ranking of Global Top Cancer Early Detection and Diagnosis Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Cancer Early Detection and Diagnosis Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Cancer Early Detection and Diagnosis, Headquarters and Area Served
Table 22. Global Key Players of Cancer Early Detection and Diagnosis, Product and Application
Table 23. Global Key Players of Cancer Early Detection and Diagnosis, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Early Detection and Diagnosis Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Cancer Early Detection and Diagnosis Revenue Market Share by Type (2020-2025)
Table 27. Global Cancer Early Detection and Diagnosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Cancer Early Detection and Diagnosis Revenue Market Share by Type (2026-2031)
Table 29. Global Cancer Early Detection and Diagnosis Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Cancer Early Detection and Diagnosis Revenue Market Share by Application (2020-2025)
Table 31. Global Cancer Early Detection and Diagnosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Cancer Early Detection and Diagnosis Revenue Market Share by Application (2026-2031)
Table 33. North America Cancer Early Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Cancer Early Detection and Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Cancer Early Detection and Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Cancer Early Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Cancer Early Detection and Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Cancer Early Detection and Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Cancer Early Detection and Diagnosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Cancer Early Detection and Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Cancer Early Detection and Diagnosis Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Cancer Early Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Cancer Early Detection and Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cancer Early Detection and Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Cancer Early Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Cancer Early Detection and Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Cancer Early Detection and Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 48. Exact Sciences Company Details
Table 49. Exact Sciences Business Overview
Table 50. Exact Sciences Cancer Early Detection and Diagnosis Product
Table 51. Exact Sciences Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 52. Exact Sciences Recent Development
Table 53. Grail Company Details
Table 54. Grail Business Overview
Table 55. Grail Cancer Early Detection and Diagnosis Product
Table 56. Grail Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 57. Grail Recent Development
Table 58. Genetron Health Company Details
Table 59. Genetron Health Business Overview
Table 60. Genetron Health Cancer Early Detection and Diagnosis Product
Table 61. Genetron Health Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 62. Genetron Health Recent Development
Table 63. New Horizon Health Company Details
Table 64. New Horizon Health Business Overview
Table 65. New Horizon Health Cancer Early Detection and Diagnosis Product
Table 66. New Horizon Health Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 67. New Horizon Health Recent Development
Table 68. Burning Rock Company Details
Table 69. Burning Rock Business Overview
Table 70. Burning Rock Cancer Early Detection and Diagnosis Product
Table 71. Burning Rock Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 72. Burning Rock Recent Development
Table 73. Berry Oncology Company Details
Table 74. Berry Oncology Business Overview
Table 75. Berry Oncology Cancer Early Detection and Diagnosis Product
Table 76. Berry Oncology Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 77. Berry Oncology Recent Development
Table 78. Shanghai Kunyuan Biotechnology Company Details
Table 79. Shanghai Kunyuan Biotechnology Business Overview
Table 80. Shanghai Kunyuan Biotechnology Cancer Early Detection and Diagnosis Product
Table 81. Shanghai Kunyuan Biotechnology Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 82. Shanghai Kunyuan Biotechnology Recent Development
Table 83. Oncognostic Company Details
Table 84. Oncognostic Business Overview
Table 85. Oncognostic Cancer Early Detection and Diagnosis Product
Table 86. Oncognostic Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 87. Oncognostic Recent Development
Table 88. Epigenomics Company Details
Table 89. Epigenomics Business Overview
Table 90. Epigenomics Cancer Early Detection and Diagnosis Product
Table 91. Epigenomics Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 92. Epigenomics Recent Development
Table 93. Abbott Company Details
Table 94. Abbott Business Overview
Table 95. Abbott Cancer Early Detection and Diagnosis Product
Table 96. Abbott Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 97. Abbott Recent Development
Table 98. Qiagen Company Details
Table 99. Qiagen Business Overview
Table 100. Qiagen Cancer Early Detection and Diagnosis Product
Table 101. Qiagen Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 102. Qiagen Recent Development
Table 103. iStat Biomedical Company Details
Table 104. iStat Biomedical Business Overview
Table 105. iStat Biomedical Cancer Early Detection and Diagnosis Product
Table 106. iStat Biomedical Revenue in Cancer Early Detection and Diagnosis Business (2020-2025) & (US$ Million)
Table 107. iStat Biomedical Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Cancer Early Detection and Diagnosis Picture
Figure 2. Global Cancer Early Detection and Diagnosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Early Detection and Diagnosis Market Share by Type: 2024 VS 2031
Figure 4. Colorectal Cancer Features
Figure 5. Liver Cancer Features
Figure 6. Lung Cancer Features
Figure 7. Other Features
Figure 8. Global Cancer Early Detection and Diagnosis Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Cancer Early Detection and Diagnosis Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Medical Center Case Studies
Figure 12. Other Case Studies
Figure 13. Cancer Early Detection and Diagnosis Report Years Considered
Figure 14. Global Cancer Early Detection and Diagnosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Cancer Early Detection and Diagnosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Cancer Early Detection and Diagnosis Market Share by Region: 2024 VS 2031
Figure 17. Global Cancer Early Detection and Diagnosis Market Share by Players in 2024
Figure 18. Global Top Cancer Early Detection and Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Detection and Diagnosis as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Cancer Early Detection and Diagnosis Revenue in 2024
Figure 20. North America Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Cancer Early Detection and Diagnosis Market Share by Country (2020-2031)
Figure 22. United States Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cancer Early Detection and Diagnosis Market Share by Country (2020-2031)
Figure 26. Germany Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cancer Early Detection and Diagnosis Market Share by Region (2020-2031)
Figure 34. China Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cancer Early Detection and Diagnosis Market Share by Country (2020-2031)
Figure 42. Mexico Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cancer Early Detection and Diagnosis Market Share by Country (2020-2031)
Figure 46. Turkey Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Cancer Early Detection and Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Exact Sciences Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 50. Grail Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 51. Genetron Health Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 52. New Horizon Health Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 53. Burning Rock Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 54. Berry Oncology Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 55. Shanghai Kunyuan Biotechnology Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 56. Oncognostic Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 57. Epigenomics Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 58. Abbott Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 59. Qiagen Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 60. iStat Biomedical Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232